Topical phenytoin dressing versus conventional dressing in diabetic ulcers

Authors

  • Pankaj B. Bharadva Department of Surgery, Government Medical College Baroda, Vadodara, Gujarat, India
  • Dilip B. Choksi Department of Surgery, Government Medical College Baroda, Vadodara, Gujarat, India
  • Sushil Damor Department of Surgery, Government Medical College Baroda, Vadodara, Gujarat, India
  • Jigar Shah Department of Surgery, Government Medical College Baroda, Vadodara, Gujarat, India

DOI:

https://doi.org/10.18203/2349-2902.isj20171621

Keywords:

Betadine, Diabetic ulcer, Topical phenytoin

Abstract

Background: Diabetic foot ulcer is estimated to affect 15% of all diabetic individuals during their lifetime. Management requires a multisystem approach. Various techniques have been tried to treat chronic ulcers, but none was proved to be ideal.

Methods: This is a prospective randomised comparative study, where 56 patients with diabetic foot ulcers admitted in dept of surgery SSG hospital, Baroda, india were divided into two comparable groups. Of which 28 underwent topical phenytoin dressings, remaining 28 underwent Betadine dressing (5% w/v povidone – iodine solution). The variables were compared after 14 days based on rate of granulation tissue formation as percentage of ulcer surface area, wound culture-sensitivity and duration of hospital stay. Chi square test was used to compare the data at each of the assessment point in both groups.

Results: In Phenytoin group, the mean rate of healthy granulation tissue formation was 60.71%, and mean hospital stay was 23.96 days with negative culture sensitivity was 54%. The Betadine group showed, the mean rate of granulation tissue formation was 11%, and mean hospital stay was 35 days with negative culture sensitivity was 18%.

Conclusions: Topical phenytoin dressing considered as superior and cost effective in management of diabetic ulcers.

Author Biography

Pankaj B. Bharadva, Department of Surgery, Government Medical College Baroda, Vadodara, Gujarat, India

Department of Surgery

References

DaCosta ML, Regan MC, al Sader M, Leader M, Bouchier-Hayes D. Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds. Surgery. 1998;123:287-93.

Kato T, Okahashi N, Kawai S, Kato T, Inaba H, Morisaki I, Amano A. Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin. J Periodontol. 2005;76:941-50.

Moy LS, Tan EM, Holness R, Uitto J. Phenytoin modulates connective tissue metabolism and cell proliferation in human skin fibroblast cultures. Arch Dermatol. 1985;121:79-83.

Genever PG, Cunliffe WJ, Wood EJ. Influence of the extracellular matrix on fibroblast responsiveness to phenytoin using in vitro wound healing models. Br J Dermatol. 1995;133:231-5.

Swamy SM, Tan P, Zhu YZ, Lu J, Achuth HN, Moochhala S. Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004;314(3):661-6.

Pendse S. Understanding diabetic foot. Int J Diabetes Dev Ctries. 2010;30:75-9.

El Zayat SG. Preliminary experience with topical phenytoin in wound healing in a war zone. Mil Med. 1989;28:347-50.

Lodha SC, Lohiya ML, Vyas MCR, Sudha Bhandari, Goyal RR, Harsh MK. Role of phenytoin in healing large abscess cavities. Br J Surg. 1991;78:105-8.

Muthukumarasamy MG, Sivakumar G, Manoharan G. Topical phenytoin in diabetic foot ulcers. Diabetes Care. 1991;14:909-11.

Wagner FW. The dysvascular foot: a system of diagnosis and treatment. Foot Ankle. 1981;2:64-122.

Rhodes RS, Heyneman CA, Culbersten VL, Wilson SE, Phatak HM, Topical phenytoin treatment of stage II deceits ulcers in the elderly. Ann Pharmacother. 2001;35:675-81.

Patil V, Patil R, Kariholu PL, Patil LS, Shahapur P. Topical Phenytoin Application in Grade I and II Diabetic Foot Ulcers: A Prospective Study. J Clin Diagn Res. 2013;7(10):2238-40.

Bethedsa MD. ASHP drug information 2001, American Society of Health System Pharmacists. 2001.

Shapiro M. Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin sodium. Exp Med Surg. 1958;16:41-53.

Pai MR, Sitaraman N, Kotian MS. Topical phenytoin in diadetic ulcers: a double blind controlled trail. Indian J Med Sci. 2001;55:593-9.

Tauro LF, Shetty P, Dsouza NT, Mohammed S, Sucharitha S. A comparative study of efficacy of topical phenytoin vs conventional wound care in diabetic ulcers. Inter J Molec Med Scie. 2013;3(1).

Anstead GM, Hart LM, Sunahara JF. Phenytoin in wound healing Ann Pharmacother 1996;30:768-75.

Downloads

Published

2017-04-22

Issue

Section

Original Research Articles